| |
| |
|
| Insider
Information: |
Sandrock Alfred |
| Relationship: |
President and CEO, Dir... |
| City: |
Weston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
333,008 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,129,394 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
333,008 |
|
|
| Total
Value |
$5,129,394 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -10.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biogen Idec Inc |
BIIB |
Head of Research & Dev... |
2021-06-07 |
10,169 |
|
0 |
Premium* |
|
|
Voyager Therapeutics, Inc. |
VYGR |
President and CEO, Dir... |
2024-04-02 |
322,839 |
2022-03-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
80 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BIIB |
Biogen Idec Inc |
Grp SVP, Chief Medical Officer |
• • – |
2014-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
7,740 |
21,832 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Research & Development |
• • – |
2021-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
3,728 |
16,794 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
President and CEO |
• • – |
2022-03-22 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
100,000 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
President and CEO |
• • – |
2023-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
120,000 |
222,055 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
President and CEO |
• • – |
2024-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
130,000 |
347,987 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Grp SVP, Chief Medical Officer |
• • – |
2013-09-16 |
4 |
AS |
$240.10 |
$2,357,821 |
D/D |
(9,820) |
14,500 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Grp SVP, Chief Medical Officer |
• • – |
2013-10-22 |
4 |
AS |
$250.11 |
$3,759,123 |
D/D |
(15,030) |
14,500 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Grp SVP, Chief Medical Officer |
• • – |
2013-12-04 |
4 |
AS |
$285.90 |
$125,510 |
D/D |
(439) |
13,667 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Grp SVP, Chief Medical Officer |
• • – |
2014-02-11 |
4 |
AS |
$314.31 |
$655,336 |
D/D |
(2,085) |
13,667 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Grp SVP, Chief Medical Officer |
• • – |
2014-02-13 |
4 |
AS |
$316.42 |
$134,478 |
D/D |
(425) |
21,407 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Grp SVP, Chief Medical Officer |
• • – |
2014-02-26 |
4 |
AS |
$342.17 |
$358,594 |
D/D |
(1,048) |
21,407 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Grp SVP, Chief Medical Officer |
• • – |
2014-03-04 |
4 |
AS |
$342.58 |
$1,086,321 |
D/D |
(3,171) |
15,407 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Grp SVP, Chief Medical Officer |
• • – |
2014-12-04 |
4 |
AS |
$345.88 |
$152,187 |
D/D |
(440) |
14,574 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Grp SVP, Chief Medical Officer |
• • – |
2015-02-09 |
4 |
AS |
$398.05 |
$340,731 |
D/D |
(856) |
14,574 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Grp SVP, Chief Medical Officer |
• • – |
2015-02-10 |
4 |
AS |
$397.11 |
$455,039 |
D/D |
(1,143) |
14,574 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Grp SVP, Chief Medical Officer |
• • – |
2015-02-17 |
4 |
AS |
$389.11 |
$162,648 |
D/D |
(418) |
15,004 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Grp SVP, Chief Medical Officer |
• • – |
2015-03-02 |
4 |
AS |
$406.40 |
$1,299,715 |
D/D |
(3,174) |
9,004 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Grp SVP, Chief Medical Officer |
• • – |
2015-03-27 |
4 |
AS |
$430.12 |
$184,952 |
D/D |
(430) |
8,574 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP CMO Neuro & Neurodegenerat |
• • – |
2015-12-04 |
4 |
AS |
$277.00 |
$122,157 |
D/D |
(441) |
7,740 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP CMO Neuro & Neurodegenerat |
• • – |
2016-02-09 |
4 |
AS |
$246.54 |
$210,052 |
D/D |
(852) |
7,740 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP CMO Neuro & Neurodegenerat |
• • – |
2016-02-17 |
4 |
AS |
$256.16 |
$184,948 |
D/D |
(722) |
7,990 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP CMO Neuro & Neurodegenerat |
• • – |
2016-02-25 |
4 |
AS |
$261.90 |
$47,928 |
D/D |
(183) |
7,990 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP CMO Neuro & Neurodegenerat |
• • – |
2017-03-01 |
4 |
AS |
$290.07 |
$282,238 |
D/D |
(973) |
9,041 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP CMO Neuro & Neurodegenerat |
• • – |
2017-04-03 |
4 |
AS |
$274.08 |
$542,952 |
D/D |
(1,981) |
7,060 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Chief Medical Officer |
• • – |
2018-02-15 |
4 |
AS |
$298.85 |
$386,712 |
D/D |
(1,294) |
7,296 |
0 |
- |
|
80 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
